Maternal-offspring HLA-DRB1 compatibility in multiple sclerosis

Tissue Antigens

Volumn 66, Issue 1, 2005, Pages 44-47

  Willer, C J ^a   Dyment, D A ^a   Sadovnick, A D ^b   Ebers, George C ^a,c,d  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d RADCLIFFE INFIRMARY   (United Kingdom)

Author keywords

Histocompatibility; HLADR; Multiple sclerosis

Indexed keywords

HLA DR ANTIGEN;

ALLELE; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; FETOPLACENTAL UNIT; GENETIC COMPATIBILITY; GENETIC SUSCEPTIBILITY; HLA SYSTEM; HLA TYPING; HOMOZYGOSITY; HUMAN; HUMAN CELL; LONG TERM CARE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; RISK ASSESSMENT; STEM CELL;

ALLELES; FAMILY HEALTH; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HLA-DR ANTIGENS; HOMOZYGOTE; HUMANS; MALE; MOTHERS; MULTIPLE SCLEROSIS; SCLERODERMA, SYSTEMIC; STEM CELLS;

EID: 21744431752     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2005.00425.x     Document Type: Article

References (15)

1. Naito S, Namerow A, Mickey MR, Terasaki P. Multiple sclerosis association with HLA A3. Tissue Antigens 1972: 2: 1-4.
2. Nelson JL, Furst DE, Maloney S et al. Microchimerism and HLA-compatible relationships of pregnancy in scleroderma. Lancet 1998: 351: 559-62.
3. Artlett CM, Smith JB, Jimenez SA. Identification of fetal DNA and cells in skin lesions from women with systemic sclerosis. N Engl J Med 1998: 338: 1186-91.
4. Miyashita Y, Ono M, Ueki H, Kurasawa K. Y chromosome microchimerism in rheumatic autoimmune disease. Ann Rheum Dis 2000: 59: 655-6.
5. Nelson JL. Microchimerism and human autoimmune diseases. Lupus 2002: 11: 651-4.
6. Artlett CM, Welsh KI, Black CM, Jimenez SA. Fetal-maternal HLA compatibility confers susceptibility to systemic sclerosis. Immunogenetics 1997: 47: 17-22.
7. Williamson LM, Warwick RM. Transfusion-associated graft-versus-host disease and its prevention. Blood Rev 1995: 9: 251-61.
8. Wilier CJ, Sadovnick AD, Ebers GC. Microchimerism in autoimmunity and transplantation: potential relevance to multiple sclerosis. J Neuroimmunol 2002: 126: 126-33.
9. Ober C, Aldrich CL, Chervoneva I et al. Variation in the HLA-G promoter region influences miscarriage rates. Am J Hum Genet 2003: 72: 1425-35.
10. Aldrich CL, Stephenson MD, Karrison T et al. HLA-G genotypes and pregnancy outcome in couples with unexplained recurrent miscarriage. Mol Hum Reprod 2001: 7: 1167-72.
11. Sadovnick AD, Risch NJ, Ebers GC. Canadian collaborative project on genetic susceptibility to MS, phase 2: rationale and method. Canadian Collaborative Study Group. Can J Neurol Sci 1998: 25: 216-21.
12. Poser CM, Paty DW, Scheinberg L et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983: 13: 227-31.
13. Olerup O, Zetterquist H. HLA-DRB.1*01 subtyping by allele-specific PCR amplification: a sensitive, specific and rapid technique. Tissue Antigens 1991: 37: 197-204.
14. O'Connell JR, Weeks DE. PedCheck: a program for identification of genotype incompatibilities in linkage analysis. Am J Hum Genet 1998: 63: 259-66.
15. Spielman RS, McGinnis RE, Ewens WJ. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 1993: 52: 506-16.